Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first coronary or cerebrovascular ischaemic event and following coronary angioplasty or coronary artery bypass graft.

A dose of one capsule (162.5mg acetylsalicyclic acid) should be taken at the same time each day 15 minutes before food.

Flamasacard is not suitable in situations where a rapid onset of action is required, such as the acute treatment of myocardial infarction or unstable angina. In these cases immediate-release aspirin should be administered.

View Flamasacard drug record

Further information: Abbey Pharmaceuticals


Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases